Current prospects for higher effectiveness of ischemic stroke management

Acute stroke still accounts for a significant proportion in the structure of all cardiovascular diseases. Effective management of acute cerebrovascular disease may be improved by new methods of treatment. Neurotrophic and neuroprotective drugs are among the promising treatment options, represented, for example, by Cerebrolysin. The drug demonstrated a strong metabolic, neuroprotective, neuromodulatory and neurotrophic effect evidenced by numerous experimental and clinical observations